Abnormal circulating steroids refine risk of progression to heart failure in ischemic heart disease

Documenti analoghi

• Inflammation, lipids and cardiovascular risk: The quest for improving risk stratification and prognosis in ischemic heart disease
  di: Giulio Francesco Romiti, et al.
  Pubblicazione: (2024)
• A systematic analysis and prediction of the disease burden of ischemic heart disease caused by hyperglycemia
  di: Jianxing Chen, et al.
  Pubblicazione: (2025)
• Atrial fibrosis heterogeneity and atrial fibrillation risk in ischaemic heart failure
  di: Alessandro Scuricini, et al.
  Pubblicazione: (2025)
• Assessment of triglyceride‐glucose composite indices associated mortality risk in diabetes‐related heart failure
  di: Qijie Zhao, et al.
  Pubblicazione: (2026)
• Ceramide and phosphatidylcholine lipids‐based risk score predicts major cardiovascular outcomes in patients with heart failure
  di: Angelika Witoslawska, et al.
  Pubblicazione: (2024)